The genetic architecture of lipoprotein(a): simplicity, complexity, and mutability

High levels of lipoprotein(a) (Lp(a)) increase risk of cardiovascular diseases. Lp(a) concentration is primarily determined (>80%) by genetic variation at LPA , particularly by its large, size-polymorphic kringle IV-2 (KIV-2) repeat. However, because variation of the KIV-2 repeat is difficult to measure, the precise ways that genetic variants at LPA and other loci determine Lp(a) levels have been unclear, especially in individuals of non-European ancestry. Here, we developed new computational techniques to accurately genotype KIV-2 variation in whole-genome-sequenced population cohorts. Applying these methods to UK Biobank (n=490,414) and All of Us (n=245,394) provided insights into the genetic determinants of Lp(a) and the mutational dynamics of the KIV-2 repeat, which we found expands or contracts intra-allelically once every ∼500 generations. Variation in Lp(a) levels among people of all genetic ancestries was accurately predicted by a single, transferable genetic model capturing cis -epistatic effects of KIV-2 length and protein-altering polymorphisms in LPA . Controlling for predicted effects of LPA alleles revealed an additional, highly polygenic contribution to Lp(a) variation: LPA -adjusted Lp(a) levels associated with genetic variation at over 300 loci ( P <5x10 -8 ), much like other blood lipids. These results elucidate the genetic architecture and mutational origins of Lp(a) variation, showing how detailed characterization of a largely monogenic trait can provide surprising insights for complex trait genetics.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-20
DOI
https://doi.org/10.64898/2026.11.16.767202
Primary Topic
Lipoproteins and Cardiovascular Health
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The genetic architecture of lipoprotein(a): simplicity, complexity, and mutability

Simone Rubinacci, Margaux L.A. Hujoel, Nolan Kamitaki, David Shin-Hsiung Tang et al.
bioRxiv (Cold Spring Harbor Laboratory)
Lipoproteins and Cardiovascular Health
preprint

The genetic architecture of lipoprotein(a): simplicity, complexity, and mutability

Simone Rubinacci, Margaux L.A. Hujoel, Nolan Kamitaki, David Shin-Hsiung Tang, Po‐Ru Loh, Robert E. Handsaker, Steven A. McCarroll, Ronen E Mukamel
preprint en

Abstract

High levels of lipoprotein(a) (Lp(a)) increase risk of cardiovascular diseases. Lp(a) concentration is primarily determined (>80%) by genetic variation at LPA , particularly by its large, size-polymorphic kringle IV-2 (KIV-2) repeat. However, because variation of the KIV-2 repeat is difficult to measure, the precise ways that genetic variants at LPA and other loci determine Lp(a) levels have been unclear, especially in individuals of non-European ancestry. Here, we developed new computational techniques to accurately genotype KIV-2 variation in whole-genome-sequenced population cohorts. Applying these methods to UK Biobank (n=490,414) and All of Us (n=245,394) provided insights into the genetic determinants of Lp(a) and the mutational dynamics of the KIV-2 repeat, which we found expands or contracts intra-allelically once every ∼500 generations. Variation in Lp(a) levels among people of all genetic ancestries was accurately predicted by a single, transferable genetic model capturing cis -epistatic effects of KIV-2 length and protein-altering polymorphisms in LPA . Controlling for predicted effects of LPA alleles revealed an additional, highly polygenic contribution to Lp(a) variation: LPA -adjusted Lp(a) levels associated with genetic variation at over 300 loci ( P <5x10 -8 ), much like other blood lipids. These results elucidate the genetic architecture and mutational origins of Lp(a) variation, showing how detailed characterization of a largely monogenic trait can provide surprising insights for complex trait genetics.

bioRxiv (Cold Spring Harbor Laboratory)
Broad Institute (US), Brigham and Women's Hospital (US), Howard Hughes Medical Institute (US), Harvard University (US), University of California, Los Angeles (US), Institute for Molecular Medicine Finland (FI)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, National Institutes of Health
Good health and well-being
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon